IHS Chemical Week

Regions :: Western Europe :: Denmark

Novo Nordisk invests over $100 million in new purification plant in Denmark

7:28 AM MDT | March 17, 2014 | Deepti Ramesh

Health-care company Novo Nordisk (Bagsvaerd, Denmark) says it is increasing its drug development capacity by investing 550 million Danish kroner ($102 million) in a new facility at Bagsvaerd. The purification plant will expand the company’s capacity to produce active pharmaceutical ingredients for a growing number of diabetes drugs under development, Novo Nordisk says. The pilot plant will be fully operational by late 2016 and will be run by CMC Supply—chemistry, manufacturing, and control supply—a unit within Novo Nordisk R&D. CMC Supply...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa